The research results of tenders of drug supply for cancer patients in Ukraine
DOI:
https://doi.org/10.24959/cphj.15.1319Keywords:
state target programmes, cancer patients, prevalence of cancer, tender purchases of medicinesAbstract
The article presents the results of analysis of the pharmaceutical supply of patients according to the state target programme “Oncology”. For the first time the comparative analysis of the dynamics of drug procurement in current and constant prices, as well as the amounts of purchased products per one cancer patient has been carried out. It has been determined that during the period of 2009-2013 a complex dynamics of changes in the amount of the drugs purchased was observed; it did not correspond to the nature of changes in the prevalence of malignant tumors in Ukraine. During 2009-2013 there was increase in the amount of tender procurement against reduction in the total amount of drugs purchased by the international non-proprietary and trade names of drugs. On average, the state spent 219,00 UAH or 27,59 US dollars per one cancer patient. These indicators do not meet the needs of patients with cancer pathology in the available drugs that are recommended by clinical protocols for conducting courses of chemotherapy. Due to an unstable currency at the foreign exchange market and the low solvency of the population the abovementioned facts have a negative socioeconomic importance and require immediate action. A characteristic feature of the tender procurement is a significant dominance in the range of drugs imported (70.7-84.1%). As a result of the research and systematization of literature data the basic measures to improve the efficiency of pharmaceutical supply of cancer patients in Ukraine have been developed. The author has made the conclusion about the need of introduction of the cost reimbursement mechanism of drug consumption into practical healthcare in the conditions of decrease of the regulatory impact on pricing at the domestic pharmaceutical market.
References
Галковская Г. Эффективное использование средств госбюджета на закупки препаратов – законное требование налогоплательщиков [Електронний ресурс]. – Режим доступу до документа: http://www.apteka.ua/article/304636.
Євтушенко О.М., Мнушко З.М., Немцова В.Д. // Управління, економіка та забезпечення якості в фармації. – 2010. – №4. – С. 50-56.
Левицька О.Р., Борецька О.Б., Заяць М.М., Сех М.Я. // Клінічна фармація, фармакотерапія та медична стандартизація. – 2010. – №3-4. – С. 127-133.
Мнушко З.М., Шолойко Н.В. Оцінка економічної доступності лікарських препаратів, що закуповуються за бюджетні кошти // Ефективність використання маркетингу та логістики фармацевтичними організаціями: Матер. наук.-практ. конф. – Х.: Вид-во НФаУ, 2008. – С. 31.
Немченко А.С., Панфілова Г.Л., Корж Ю.В. // Управління, економіка та забезпечення якості в фармації. – 2009. – №3 (5). – С. 65-71.
Немченко А.С., Косяченко К.Л., Панфілова Г.Л. Методика проведення клініко-економічного аналізу тендерних закупівель ЛЗ за державними цільовими програмами: Метод. рекоменд. – Х.: НФаУ, 2011. – 26 с.
Снєгірьов П. Державні закупівлі ліків. Формування очікуваної ціни, або МОЗ України відшукує всі можливі шляхи для подолання тендерної кризи [Електронний ресурс]. – Режим доступу до документа: http://www.apteka.ua/article/302993.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).